In a document unsealed in federal court in Illinois, former FDA Commissioner David Kessler charged that Bayer, the manufacturer of the popular birth control drug Yasmin failed to report scientific data that showed the drug was associated with blood clots in women taking the medication. Kessler also stated that Bayer marketed Yasmin for uses for which the federal agency had not provided specific approval.
Both allegations will play a significant role in ongoing Yasmin birth control lawsuits across the country.
According to Bloomberg News, ““Bayer presented a selective view of the data, and that presentation obscured the potential risks associated with Yasmin,” Kessler said. The company also promoted the oral contraceptive for unapproved uses, particularly for treatment of premenstrual syndrome, said Kessler.”
- Epidurals and Autism - October 30, 2020
- 1 in 20 Patients Harmed by Medical Errors, New Report Finds - August 1, 2019
- Errors in Electronic Health Records: A Growing Source forMedical Malpractice Claims - May 23, 2018